Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Liposome initiates clinical trial of Evacet in combination with Herceptin

Aug. 6, 1999

Combination immunotherapy kills melanoma in mice

Aug. 6, 1999

Promising troponin I analogue identified

Aug. 5, 1999

Radicicol derivative depletes Hsp90-associated molecules, exhibits antitumor activity

Aug. 5, 1999

U.K. academics isolate novel cytotoxic agent from cyanobacterium

Aug. 4, 1999

Paxene launched in the Czech Republic

Aug. 4, 1999

Kirin Brewery patents quinoline derivatives with broad potential therapeutic application

Aug. 3, 1999

Licensing opportunity from NIH: method of inhibiting Hsp90 with novobiocin

Aug. 3, 1999

Ontogen completes phase I bioavailability study of MDR-modulating compound

Aug. 3, 1999

Solimastat is a potent MMP inhibitor with significant advantages over related compounds

Aug. 2, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Aug. 3, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...